SCHEMBL3435970

SCHEMBL3435970

O=C(OS(=O)(=O)O)c1n[nH]c(O)c1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.43
ALDH1A1 P00352 3/20 0.43
GAA P10253 2/20 0.38
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
KDM4E B2RXH2 3/20 0.33
HPGDS O60760 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
STAT3 P40763 1/20 0.33
HIF1A Q16665 1/20 0.33
RPS6KA3 P51812 2/20 0.33
CHEK1 O14757 2/20 0.33
RET P07949 1/20 0.33
PDGFRB P09619 1/20 0.33
PIM1 P11309 1/20 0.33
PDGFRA P16234 1/20 0.33
GSK3B P49841 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7403288 0.78 LMNA (0.49) LMNAALDH1A1TP53SMN1; SMN2KDM4E
SCHEMBL7402340 0.77 LMNA (0.70) LMNAALDH1A1GAATP53SMN1; SMN2
SCHEMBL27455057 0.77 LMNA (0.47) LMNAALDH1A1TP53SMN1; SMN2KDM4E
SCHEMBL2222532 0.71 ENPP2 (0.41) LMNAALDH1A1SMN1; SMN2KDM4EADORA2A
SCHEMBL571266 0.66 ALDH1A1 (0.46) LMNAALDH1A1GAATP53SMN1; SMN2
SCHEMBL3435968 0.66 PGAM1 (0.39) LMNAALDH1A1KDM4EHIF1AMAPT
SCHEMBL15713879 0.66 MEN1 (0.49) LMNAALDH1A1GAATP53SMN1; SMN2
SCHEMBL4818821 0.65 LMNA (0.56) LMNAALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL4749775 0.64 AKT2 (0.66) TP53RPS6KA3CHEK1RETPDGFRB
SCHEMBL16260565 0.64 KDM4E (0.57) LMNAALDH1A1GAASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3658106-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2020-06-03 EP disclosed
WO-2019045781-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2019-03-07 WO disclosed
EP-3365028-A1 DETECTION AND TREATMENT OF CARIES AND MICROCAVITIES WITH NANOPARTICLES The Regents of The University of Michigan (US) 2018-08-29 EP disclosed
WO-2017070578-A1 DETECTION AND TREATMENT OF CARIES AND MICROCAVITIES WITH NANOPARTICLES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-04-27 WO disclosed
CN-103596545-A Stabilization of zinc oxide films in oral compositions COLGATE PALMOLIVE CO 2014-02-19 CN disclosed
CN-103096979-A Oral care formulations for malodor control COLGATE PALMOLIVE CO 2013-05-08 CN disclosed
EP-2249770-A2 DUAL COMPONENT ORAL CARE PRODUCT Colgate-Palmolive Company (US) 2010-11-17 EP disclosed
WO-2009100268-A2 DUAL COMPONENT ORAL CARE PRODUCT COLGATE-PALMOLIVE COMPANY (US) 2009-08-13 WO disclosed
CN-1191052-C Dual component dentinal desensitizing dentifrice COLGATE PALMOLIVE CO (US) 2005-03-02 CN disclosed
CN-1343112-A Dual component dentinal desensitizing dentifrice COLGATE PALMOLIVE CO (US) 2002-04-03 CN disclosed